Related Experiment Video

Updated: Sep 25, 2026

Neural Tube Closure in Mouse Whole Embryo Culture
07:37

Neural Tube Closure in Mouse Whole Embryo Culture

Published on: October 21, 2011

Pharmacology of neural tube defects

C E Pippenger1

  • 1Department of Biomedical and Health Sciences, Grand Valley State University, Allendale, Michigan, USA. cepip@iserv.net

Epilepsia
|June 7, 2003
PubMed

Insights

Chronic drug therapy, particularly antiepileptic drugs (AEDs), can increase the risk of neural tube defects (NTDs) by generating harmful free radicals (FRs). Antioxidant defenses may be overwhelmed, leading to congenital defects.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Developmental Biology

Background:

  • Neural tube defects (NTDs) result from complex interactions between genetic, environmental, and biochemical factors.
  • Chronic drug therapy can lead to the formation of toxic drug metabolites, including free radicals (FRs), implicated in NTD etiology.
  • FR-mediated cellular damage occurs when antioxidant defense systems are compromised.

Purpose of the Study:

  • To review the biochemistry of FRs and factors regulating antioxidant capacity.
  • To explore theories on NTD etiology, focusing on FRs.
  • To propose a unified mechanism for AED-induced NTDs and discuss preventive roles of folate and selenium.

Main Methods:

  • Literature review of FR biochemistry and NTD etiology.
  • Analysis of factors influencing FR scavenging enzyme activity (FRSEA).
  • Hypothesis formulation for AED-induced NTDs.

Main Results:

  • FRs generated during drug metabolism, especially from AEDs, are linked to increased NTD risk.
  • Genetic deficiencies in FRSEA or chronic drug therapy can overwhelm antioxidant defenses.
  • Congenital defects, including NTDs, have been associated with FR-induced damage in humans and animals.

Conclusions:

  • A unified mechanism involving FRs may explain AED-induced NTDs and other congenital defects.
  • Antioxidant status and drug metabolism pathways are critical in NTD development.
  • Folate and selenium may play roles in preventing NTDs.

More Related Videos

Monitoring the Mechanical Evolution of Tissue During Neural Tube Closure of Chick Embryo05:51

Monitoring the Mechanical Evolution of Tissue During Neural Tube Closure of Chick Embryo

Published on: November 10, 2023

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...